Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Endocr Pract ; 6(6): 460-4, 2000.
Article in English | MEDLINE | ID: mdl-11155220

ABSTRACT

OBJECTIVE: To describe the use of recombinant human thyrotropin (thyroid-stimulating hormone) (rhTSH) to assist in radioiodine therapy in a patient with thyroid carcinoma who was unable to produce sufficient endogenous thyrotropin when hypothyroid and to review the related literature. METHODS: The study patient underwent formal dosimetric analysis and received radioiodine in conjunction with rhTSH. Follow-up scanning studies were performed. RESULTS: We found good localization of radioiodine on the posttherapy scans after administration of (131)I while the patient continued to receive thyroxine replacement after two intramuscularly administered injections of rhTSH. Some of his metastatic lesions disappeared and his serum thyroglobulin level decreased after the first rhTSH-assisted dose of (131)I was administered. His blood radioiodine clearance rate was unexpectedly more rapid in the hypothyroid state than when he was euthyroid (taking thyroxine) after administration of rhTSH. His whole-body clearance rate was more delayed when he was hypothyroid. Swelling of some of the metastatic thyroid cancer lesions developed when the patient was hypothyroid and after rhTSH was administered, the latter being much more rapid in onset. CONCLUSION: Therapeutic doses of radioiodine can be delivered with the assistance of rhTSH administration while patients continue to take suppressive doses of thyroxine. Metastatic thyroid carcinoma lesions can swell rapidly after administration of rhTSH. The commercially available form of rhTSH is approved only for diagnostic use. Its safety and efficacy in assisting radioiodine therapy have not been fully determined.


Subject(s)
Adenocarcinoma, Follicular/radiotherapy , Adenocarcinoma, Follicular/secondary , Bone Neoplasms/radiotherapy , Bone Neoplasms/secondary , Iodine Radioisotopes/therapeutic use , Thyroid Neoplasms/pathology , Thyrotropin/therapeutic use , Adenocarcinoma, Follicular/diagnostic imaging , Bone Neoplasms/diagnostic imaging , Brain Neoplasms/radiotherapy , Brain Neoplasms/secondary , Brain Neoplasms/surgery , Drug Synergism , Empathy , Humans , Male , Middle Aged , Radionuclide Imaging , Recombinant Proteins , Thyroid Neoplasms/surgery , Thyroxine/therapeutic use
2.
J Hand Ther ; 6(1): 29-34, 1993.
Article in English | MEDLINE | ID: mdl-8343872

ABSTRACT

The clinical reliability of torque range of motion (TROM) has not been tested. This preliminary review was performed to determine the intra- and interrater reliability of TROM. The proximal interphalangeal joints of the index and middle fingers of 14 normal subjects, 56 digits, were tested by applying extension forces of 200 g, 400 g, 600 g, and 800 g. Data were collected using both the hand-held Haldex orthotic gauge with the dial goniometer (manual) and the cantilever-beam force transducer and electrogoniometer (digital) as testing instruments. The testing order of digits, sides, and devices was randomized and tested separately by three different test teams. Results of the analysis of variance showed a significant difference of the means between raters at all force levels (p < 0.0001) and between instruments at 600-g and 800-g forces (p < 0.01). The Pearson product-moment correlation coefficient test, used to test the consistency, resulted in moderate consistency of measures of intrarater reliability between trials, and between instruments used (digital and manual). Intraclass correlation coefficients (ICCs) were calculated with results that were nearly identical to those of the Pearson. Intrarater reliability was in more consistent agreement at the 600-g and 800-g levels. There was significantly high agreement between the tests of tester B, compared with moderate correlations of the tests of testers A and C.


Subject(s)
Finger Joint/physiology , Range of Motion, Articular , Adult , Biomechanical Phenomena , Electrophysiology/instrumentation , Electrophysiology/methods , Female , Humans , Male , Middle Aged , Torsion Abnormality
3.
Am J Epidemiol ; 101(4): 323-32, 1975 Apr.
Article in English | MEDLINE | ID: mdl-1092157

ABSTRACT

In November 1972 an outbreak of gastrointestinal illness occurred at a public school in Stockport, Iowa. One hundred ninety-four (72%) of 269 pupils and 14 (16%) of 23 staff members were affected. The etiologic agent was a strain of Shigella sonnei resistant to multiple antimicrobials. Waterborne transmission of shigellosis was documented epidemiologically and by isolation of the organism from the school water system. Ninety-seven (14%) of 698 of the students' household contacts developed diarrhea, and possible secondary cases also occurred in 3 (9%) of 32 household contacts of school staff.


Subject(s)
Disease Outbreaks/epidemiology , Dysentery, Bacillary/epidemiology , School Health Services , Shigella sonnei , Water Microbiology , Water Supply , Drug Resistance, Microbial , Dysentery, Bacillary/genetics , Dysentery, Bacillary/transmission , Iowa , Rectum/microbiology , Shigella sonnei/isolation & purification , Water Pollution
SELECTION OF CITATIONS
SEARCH DETAIL
...